NL7215229A - - Google Patents

Info

Publication number
NL7215229A
NL7215229A NL7215229A NL7215229A NL7215229A NL 7215229 A NL7215229 A NL 7215229A NL 7215229 A NL7215229 A NL 7215229A NL 7215229 A NL7215229 A NL 7215229A NL 7215229 A NL7215229 A NL 7215229A
Authority
NL
Netherlands
Application number
NL7215229A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7215229A publication Critical patent/NL7215229A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/005—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0023—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16
    • C07J5/003—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes
    • C07J5/0038—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes by an alkyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/0025—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa substituted in position 16
    • C07J7/003—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/0065—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified
    • C07J7/007—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified not substituted in position 17 alfa

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NL7215229A 1971-11-11 1972-11-10 NL7215229A (cg-RX-API-DMAC7.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5246571A GB1409239A (en) 1971-11-11 1971-11-11 Process for the preparation of 3alpha-hydroxy-5alpha-steroids

Publications (1)

Publication Number Publication Date
NL7215229A true NL7215229A (cg-RX-API-DMAC7.html) 1973-05-15

Family

ID=10464018

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7215229A NL7215229A (cg-RX-API-DMAC7.html) 1971-11-11 1972-11-10

Country Status (8)

Country Link
US (1) US3822298A (cg-RX-API-DMAC7.html)
JP (1) JPS5725560B2 (cg-RX-API-DMAC7.html)
CA (1) CA972744A (cg-RX-API-DMAC7.html)
CH (1) CH606097A5 (cg-RX-API-DMAC7.html)
DK (1) DK133470B (cg-RX-API-DMAC7.html)
FR (1) FR2177695B1 (cg-RX-API-DMAC7.html)
GB (1) GB1409239A (cg-RX-API-DMAC7.html)
NL (1) NL7215229A (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3969345A (en) * 1970-12-17 1976-07-13 Glaxo Laboratories Limited 20β,21-Epoxy-3α-hydroxy-5α-pregnanes and derivatives thereof
DE2438020A1 (de) * 1974-08-05 1976-02-26 Schering Ag 18-methyl-19-nor-20-keto-pregnane und verfahren zu ihrer herstellung
US4557946A (en) * 1983-06-03 1985-12-10 Edward Sacher Moisture impermeability or organosilicone films
JPS6150568U (cg-RX-API-DMAC7.html) * 1984-09-04 1986-04-04
US5232917A (en) * 1987-08-25 1993-08-03 University Of Southern California Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
PT837874E (pt) * 1995-06-06 2005-03-31 Euro Celtique Sa Esteroides neuroactivos da serie androstano e pregnano
US6780853B1 (en) 1995-06-06 2004-08-24 Euro-Celtique S.A. Neuroactive steroids of the androstane and pregnane series
WO2020231837A1 (en) 2019-05-10 2020-11-19 Brii Biosciences, Inc. Pharmaceutical composition containing brexanolone, ganaxolone, or zuranolone, and use thereof
WO2021142477A1 (en) * 2020-01-12 2021-07-15 Brii Biosciences, Inc. Neuroactive steroids and pharmaceutical composition containing the same
CN116478229B (zh) * 2023-04-25 2025-07-11 上海格苓凯生物科技有限公司 一种利用布瑞诺龙制备阿法沙龙的方法

Also Published As

Publication number Publication date
GB1409239A (en) 1975-10-08
CA972744A (en) 1975-08-12
DK133470B (da) 1976-05-24
FR2177695B1 (cg-RX-API-DMAC7.html) 1976-07-02
FR2177695A1 (cg-RX-API-DMAC7.html) 1973-11-09
CH606097A5 (cg-RX-API-DMAC7.html) 1978-10-13
JPS5725560B2 (cg-RX-API-DMAC7.html) 1982-05-29
US3822298A (en) 1974-07-02
JPS4867263A (cg-RX-API-DMAC7.html) 1973-09-13
DK133470C (cg-RX-API-DMAC7.html) 1976-11-15
DE2255108B2 (de) 1976-12-02
DE2255108A1 (de) 1973-08-09

Similar Documents

Publication Publication Date Title
JPS5725560B2 (cg-RX-API-DMAC7.html)
FR2122057A5 (cg-RX-API-DMAC7.html)
CS160061B2 (cg-RX-API-DMAC7.html)
FR2083174A5 (cg-RX-API-DMAC7.html)
FR2124286B1 (cg-RX-API-DMAC7.html)
DE2156768A1 (cg-RX-API-DMAC7.html)
FR2122582A1 (cg-RX-API-DMAC7.html)
FR2078589A5 (cg-RX-API-DMAC7.html)
FR2119421A5 (cg-RX-API-DMAC7.html)
DE2116581A1 (cg-RX-API-DMAC7.html)
CS151605B1 (cg-RX-API-DMAC7.html)
FR2124042B1 (cg-RX-API-DMAC7.html)
AU3279171A (cg-RX-API-DMAC7.html)
CS161950B2 (cg-RX-API-DMAC7.html)
CS153400B1 (cg-RX-API-DMAC7.html)
FR2121660A1 (cg-RX-API-DMAC7.html)
CS149142B1 (cg-RX-API-DMAC7.html)
CS157888B1 (cg-RX-API-DMAC7.html)
CS151769B1 (cg-RX-API-DMAC7.html)
CS166796B2 (cg-RX-API-DMAC7.html)
CS156106B1 (cg-RX-API-DMAC7.html)
DE7149067U (cg-RX-API-DMAC7.html)
CS150048B1 (cg-RX-API-DMAC7.html)
CH561072A5 (cg-RX-API-DMAC7.html)
CH564026A5 (cg-RX-API-DMAC7.html)

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
A85 Still pending on 85-01-01
BV The patent application has lapsed